Position in PFE
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$948,535
-$157,564 QoQ
Shares Held
39,391
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
#1,353
of 2,821 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026St. Clair Advisors, LLC holds $10,019,901 across 6 Drug Manufacturers - General names. PFE ranks #4 (9.5% of the industry book) .
All Filings in PFE
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $948,535 | 39,391 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $1,106,099 | 39,391 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $953,744 | 38,303 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $918,630 | 36,053 | Shares | Sole | 2025-10-03 | |
| 2025-06-30 | $871,840 | 35,967 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $911,403 | 35,967 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $954,204 | 35,967 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,040,884 | 35,967 | Shares | Sole | 2025-04-10 | |
| 2024-06-30 | $1,006,356 | 35,967 | Shares | Sole | 2025-04-10 | |
| 2024-03-31 | $998,084 | 35,967 | Shares | Sole | 2025-04-10 | |
| 2023-12-31 | $1,035,489 | 35,967 | Shares | Sole | 2025-04-10 | |
| 2023-09-30 | $1,212,927 | 36,567 | Shares | Sole | 2025-04-10 | |
| 2023-06-30 | $1,341,277 | 36,567 | Shares | Sole | 2025-04-10 | |
| 2023-03-31 | $1,237,096 | 30,321 | Shares | Sole | 2025-04-10 | |
| 2022-12-31 | $576,501 | 11,251 | Shares | Sole | 2025-04-10 | |
| No filing history on record for this holder in this stock. | ||||||